Lexicon Pharmaceuticals, Inc.
- LXRX
- NASDAQ
- Biotechnology
- Small-Molecule Drugs
- Cardiometabolic Disease (Sotagliflozin)
$1.55
Today +1.97%Quote Oct 19, 2026, 08:00 PM UTC
−24.39%over the last month
Max drawdown −30.3%From 1-month high −28.9%3 months −34.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Lexicon Pharmaceuticals
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
81
Market value
$689.7M
Quote Oct 19
Analyst target
$6.00
+287.1% from here
Floor
$1.52
2.0% below price
Resistance
$1.57
1.5% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LXRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free